Calendar Illumina, Inc.

Equities

ILMN

US4523271090

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 16:00:00 2026-02-13 EST			5-day change	1st Jan Change
116.81 ^USD	+2.07%		-2.43%	-10.94%

02-06	UBS Adjusts Illumina Price Target to $135 From $120, Maintains Neutral Rating	MT
02-05	Illumina, Inc., Q4 2025 Earnings Call, Feb 05, 2026

Chart calendar Illumina, Inc.

3605fc436f92e2e4e4a4963878.mQQZb4iiydwPzY3iADI5v7jSlLswgj85v-gevpz7pEE.1G50P72SrLg3oPiXZ39Qx5Wl3ZZv21B4zqJG1c6a_XjSdl0D-Oz8pH-8uQ~0fcf4fe66b7cc21f8f70db001860a853

Upcoming events on Illumina, Inc.

2026-04-27	Q1 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-08-11	Q2 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-10-28	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2027-02-10	Q4 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format

Past events on Illumina, Inc.

2026-02-05	Q4 2025 Earnings Call
2026-02-05	Q4 2025 Earnings Release
2026-01-13	J.P. Morgan Healthcare Conference - Q&A
2026-01-13	J.P. Morgan Healthcare Conference
2025-11-19	Wolfe Research Healthcare Conference
2025-10-30	Q3 2025 Earnings Call
2025-10-30	Q3 2025 Earnings Release
2025-10-15	American Society of Human Genetics Meeting
2025-07-31	Q2 2025 Earnings Call
2025-07-31	Q2 2025 Earnings Release
2025-05-28	Bernstein Strategic Decisions Conference
2025-05-21	Annual General Meeting
2025-05-08	Q1 2025 Earnings Call
2025-05-08	Q1 2025 Earnings Release
2025-02-25	Advances in Genome Biology and Technology Conference - Bekim Sadikovic
2025-02-25	Advances in Genome Biology and Technology Conference
2025-02-24	Advances in Genome Biology and Technology Conference - Stephen Kingsmore
2025-02-24	Advances in Genome Biology and Technology Conference - Gold Sponsor Workshop
2025-02-06	Q4 2024 Earnings Call
2025-02-06	Q4 2024 Earnings Release

Annual results

Fiscal Period	December	2023	2024	2025	2026	2027	2028
Net sales Million USD	Released Forecast Spread	4 504 4 474 0.67%	4 372 4 339 0.76%	4 343 4 298 1.05%	4 536	4 782	5 096
EBITDA Million USD	Released Forecast Spread	488 498 -2.05%	807 1 124 -28.19%	1 208 1 178 2.55%	1 343	1 502	1 529
EBIT Million USD	Released Forecast Spread	247 446 -44.6%	580 857 -32.35%	1 004 980 2.43%	1 058	1 184	1 323
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-1 117 -1 063 -5.13%	-1 179 -939 -25.53%	1 086 941 15.35%	931	1 038	1 224
Net income Million USD	Released Forecast Spread	-1 161 -1 146 -1.35%	-1 223 -1 038 -17.77%	850 720 18.03%	770	861	1 025
EPS USD	Released Forecast Spread	-7,34 -7,22 -1.68%	-7,69 -6,96 -10.5%	5,45 4,76 14.45%	4,71	5,32	6,66
Announcement Date		08/02/24	06/02/25	05/02/26	-

Quarterly results

Fiscal Period	December	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3	2027 Q4
Net sales Million USD	Released Forecast Spread	1 112 1 085 2.45%	1 080 1 080 0.01%	1 104 1 103 0.05%	1 041 1 037 0.4%	1 059 1 052 0.68%	1 084 1 065 1.76%	1 159 1 111 4.34%	1 073	1 106	1 143	1 217	1 131	1 162	1 208	1 274
EBITDA Million USD	Released Forecast Spread	143 245 -41.61%	330 263 25.65%	273 264 3.37%	264 258 2.2%	303 265 14.28%	316 273 15.62%	326 294 11.03%	293	331	351	389	349	378	396	419
EBIT Million USD	Released Forecast Spread	84,0 197 -57.31%	244 216 13.01%	218 218 0.05%	212 211 0.48%	252 221 13.85%	265 232 14.37%	275 253 8.68%	222	256	279	301	264	289	312	331
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-1 976	720 127 466.71%	188 428 -56.1%	182 150 21.47%	306 169 81.49%	220 202 9.15%	378 315 20.02%	190	212	234	253	225	246	269	290
Net income Million USD	Released Forecast Spread	-1 988	705 77,0 815.19%	187 125 50.2%	131 96,2 36.21%	235 125 87.95%	150 160 -6.43%	334 328 1.92%	146	172	191	215	176	192	210	227
EPS USD	Released Forecast Spread	-12,5 -5,23 -138.62%	4,42 0,61 624.59%	1,17 0,82 42.68%	0,82 0,66 23.87%	1,49 0,85 75.71%	0,98 1,08 -9.08%	2,16 1,49 44.79%	0,95	1,13	1,26	1,37	1,15	1,27	1,40	1,50
Announcement Date		06/08/24	04/11/24	06/02/25	08/05/25	31/07/25	30/10/25	05/02/26	-	-	-	-	-	-	-	-

Upcoming sector events for Illumina, Inc.

2026-02-17	BETA BIONICS, INC.	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
2026-02-19	INTEGER HOLDINGS CORPORATION	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
2026-02-19	PULSE BIOSCIENCES, INC.	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
2026-02-23	AXOGEN, INC.	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
2026-02-23	NANOSONICS LIMITED	Q2 2026 Earnings Release	Add to your calendar Google Apple ICS format
2026-02-24	TRANSMEDICS GROUP, INC.	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
2026-02-24	AGILENT TECHNOLOGIES, INC.	Q1 2026 Earnings Release	Add to your calendar Google Apple ICS format
2026-02-25	LEMAITRE VASCULAR, INC.	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
2026-02-26	BUTTERFLY NETWORK, INC.	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
2026-02-26	CYTEK BIOSCIENCES, INC.	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format

More events

Past sector events for Illumina, Inc.

2026-02-13	OLYMPUS CORPORATION	Q3 2026 Earnings Release
2026-02-12	CLASSYS INC.	Q4 2025 Earnings Release
2026-02-12	PACIFIC BIOSCIENCES OF CALIFORNIA, INC.	Q4 2025 Earnings Release
2026-02-12	BRUKER CORPORATION	Q4 2025 Earnings Release
2026-02-12	CARL ZEISS MEDITEC AG	Q1 2026 Earnings Release
2026-02-10	EDWARDS LIFESCIENCES CORPORATION	Q4 2025 Earnings Release
2026-02-10	INMODE LTD.	Q4 2025 Earnings Release
2026-02-10	PHILIPS NV	Q4 2025 Earnings Release
2026-02-09	PREMIER, INC.	Q2 2026 Earnings Release (Projected)
2026-02-09	WATERS CORPORATION	Q4 2025 Earnings Release